Skip to main content
Takeda Pharmaceutical Company Limited (TYO:4502)
Japan flag Japan · Delayed Price · Currency is JPY
4,308.00
+56.00 (1.32%)
May 30, 2025, 1:45 PM JST

TYO:4502 Revenue

In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T JPY with 7.45% growth. Takeda Pharmaceutical Company had revenue of 1.05T in the quarter ending March 31, 2025, with 0.24% growth.

Revenue
4,581.55B
Revenue Growth
+7.45%
P/S Ratio
1.45
Revenue / Employee
92.97M
Employees
49,281
Market Cap
6,640.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20254,581.55B317.79B7.45%
Mar 31, 20244,263.76B236.28B5.87%
Mar 31, 20234,027.48B458.47B12.85%
Mar 31, 20223,569.01B371.19B11.61%
Mar 31, 20213,197.81B-93.38B-2.84%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,222.12B
Daiichi Sankyo Company 1,886.26B
HOYA Corporation 869.37B
Terumo 1,036.17B
Otsuka Holdings 2,393.18B
Astellas Pharma 1,912.32B
Shionogi & 438.30B
Olympus 997.33B
Revenue Rankings

Takeda Pharmaceutical Company News

More News